Teva Pharmaceutical Industries Ltd. — Earnings Release 2009

Oct 17, 2009

_________ false

C002��� ������ ��������� ��"�2PublicTEVA- PHARMACEUTICAL INDUSTRIES LTD.7217Corporation no: 520013954Stock Exchange/Market: ���310380P.O.B 3190 , Petach Tikva 49131 , ,Tel: 03-9267554 , 03-9267652 Fax: 03-9267519E.mail address: elana.holzman@teva.co.ilDate of transmission: 17/10/2009              Time of broadcast: 20:51 20:50:29

Reference: 2009-02-257076

Israel Securities Authority		Tel Aviv Stock Exchange
www.isa.gov.il		www.tase.co.il

Immediate ReportRegulation 4 of the Securities Regulations, (Periodic and Immediate Reports of Foreign Corporation) 5761-2000

The corporation is a foreign private issuer as defined by U.S. Securities Laws.
Attached hereto is a report on TEVA TO REPORT THIRD QUARTER 2009FINANCIAL RESULTS ON NOVEMBER 3, 2009
TevaQ309_Earnings_CC_isa.pdf

Enclosed please find a press release issued on Oct 15, 2009 in the U.S.
References of previous documents relating to this matter(the reference does not constitute incorporation by reference):
Previous names of reporting entity:
Date of revision of form structure: 12/07/2009
- - -
Name of the Signatory: : Desheh Eyal , Position of Signatory in the reporting corporation: Chief Financial Officer , Name of Employer Company: .
Basel Telephone: 02-9411717 , Facsimile: 02-9411718 , E-mail: eyal@teva.co.il 2